About Human BioSciences
Human BioSciences is a Healthcare company based in Gaithersburg (United States) founded in 1990 by Manoj Jain. It develops and manufactures medical-grade wound care solutions using collagen technology. It operates on a B2B and D2C model. Its chief executive, as recorded, is Manoj Jain. Its Indian entity Human Biosciences India Limited reported revenue of ₹3.21 Cr. Human BioSciences offers products and services including Medifil® II, SkinTemp® II, and Collatek® Gel. Its focus areas include Pharmaceuticals, Wound Management, Therapeutic Products and Medical Devices. Its competitors include Claris Bio, Tempo Therapeutics and Nuo Therapeutics; 3 of its 3 listed competitors have raised funding.
Company details
Human BioSciences focuses on creating and supplying collagen-based products for wound healing and care. They offer prescription and over-the-counter items like Medifil II and SkinTemp II, along with research and manufacturing services. Based in Gaithersburg, MD, USA, and Ahmedabad, India, they serve patients, professionals, and partners through collaborations and online platforms, emphasizing innovation in healthcare.
- Headquarters Gaithersburg, United States
- Founders Manoj Jain
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website humanbiosciences.com
- Social LinkedIn X Facebook Instagram YouTube
- Legal Name Human Biosciences India Limited
- Date of Incorporation 11 Sep, 2000
- Jurisdiction New Delhi, Delhi, India
- Indian entity revenue₹3.21 Cr
FY 2025 · -30% YoY
- Indian entity net loss-₹3.26 Cr
FY 2025 · -101% margin
- Indian entity EBITDA-₹39.2 Lakh
FY 2025 · -12% margin
Associated legal entities of Human BioSciences
Human BioSciences operates through Human Biosciences India Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Human Biosciences India Limited CIN U24239DL2000PLC107655 | Active | 11 Sep 2000 | Delhi, Delhi | ₹3.2 Cr | 1 | 3 | View details |
Products & Services of Human BioSciences
Human BioSciences offers a comprehensive portfolio of products and services, including Medifil® II, SkinTemp® II, and Collatek® Gel.
Collagen dressing for effective wound healing and management.
Skin substitute aiding in wound recovery and tissue repair.
Gel formulation for treating various types of wounds.
Apps and channels of Human BioSciences
its YouTube channel Human BioSciences, Inc. USA has 40 subscribers and 4 videos.
Videos from Human BioSciences
The most watched videos on Human BioSciences's YouTube channel, Human BioSciences, Inc. USA (40 subscribers). Click a video to play it here.
More on Human BioSciences, Inc. USA.
Board of directors of Human Biosciences India Limited (Human BioSciences)
Human Biosciences India Limited is the primary company behind Human BioSciences. The board of Human Biosciences India Limited currently have 3 directors; the longest-serving is Kolluru Venkata Surya Prakash, appointed in 2008. 12 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Kolluru Venkata Surya Prakash DIN 01013474 | Director | 13 Oct 2008 | 18 yrs | Human Biosciences India Limited |
| Manoj Kumar Jain DIN 02814153 | Managing Director | 05 Oct 2009 | 17 yrs | Human Biosciences India Limited |
| Ashok Kantilal Shah DIN 01675383 | Director | 23 Mar 2013 | 13 yrs 7 mo | Human Biosciences India Limited |
People of Human BioSciences
14 people are tracked at Human BioSciences (5 in leadership, 9 in team).
| Name | Role | Group |
|---|---|---|
| Founder, CEO | Leadership | |
Rohan K. Jain | President | Leadership |
Nisha Jain | Creative Director | Leadership |
Jigar Patel | VP of Operations | Leadership |
Hardik Shah | Director Of Operations | Leadership |
Rajeev Kumar | State Manager | Team |
Utkarsh Khare | B.m. | Team |
Priyanka Mehta | Sales And Marketing | Team |
Aurindam Bakshi | Microbiologist (production&qc) | Team |
Vikas Pandey | Business Maneger | Team |
Hbs Prabhu | Business Manager | Team |
Vishal Sharma | Bussiness Manager | Team |
Yadwinder Singh | Account Manager | Team |
Ashish Bhargava | Trritory Business Manager | Team |
Complete people profiles for Human BioSciences
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Human BioSciences
Figures of Human Biosciences India Limited, the primary company behind Human BioSciences, for FY 2025. Revenue was ₹3.21 Cr (-30% year on year). Net loss was -₹3.26 Cr (-101% margin). EBITDA was -₹39.2 Lakh (-12% margin). Revenue has grown at a compounded annual rate of +40% over three years and +98% over five years.
- ₹3.21 CrRevenue · FY 2025 · -30% YoY
- -₹3.26 CrNet loss · -101% margin
- -₹39.2 LakhEBITDA · -12% margin
- ₹29.12 CrPaid-up capital
- 1Employees (provident fund records)
- +40%Revenue CAGR, 3 years
- +98%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Human Biosciences India Limited are on its company page.
Detailed financial statements for Human BioSciences
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Human BioSciences
Human BioSciences has 3 listed competitors in our database, 3 of them funded. They include Claris Bio, Tempo Therapeutics and Nuo Therapeutics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| clarisbio.com | 2018 | Jersey, United States | $44.5M | Topical formulations for corneal wounds, ulcers, and scars are developed. | ||
| tempothera.com | 2014 | San Diego, United States | $20.17M | Regenerative biomaterials for wounds are developed using particle technology. | ||
| nuot.com | 2001 | Gaithersburg, United States | $69.12M | 10 | Regenerative therapies for wound care and ulcers are developed. |
Detailed competitors of Human BioSciences
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Human BioSciences
The website of Human BioSciences (humanbiosciences.com) receives about 5K visits a month.
- Monthly visits5K
▲ 70.8% vs previous month
Top companies in Wound Care
3 companies that operate in the same segment as Human BioSciences (Wound Care) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Nanotech-based wound care products are developed and provided. | 2010 | Madison, Wisconsin, United States | USD 22.7 M | 35 | ||
Regenerative biomaterial products and bioimplants for wound, surgical, sports medicine and orthopedics | 1985 | Marietta, Georgia, United States | USD 418.63 M | 837 | ||
Developer of hemostatic products for wound care | 2010 | New York, New York, United States | USD 113.35 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Human Biosciences
Complete news archive for Human BioSciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Human BioSciences
Human BioSciences was founded in 1990.
Human BioSciences is headquartered in Gaithersburg, United States. It is registered at Gaithersburg, Maryland, United States.
Manoj Jain is the CEO of Human BioSciences, as recorded in our data. They have also founded this company.
The primary company behind Human BioSciences, Human Biosciences India Limited, reported revenue of ₹3.21 Cr for FY 2025, down 30% year on year.
Human BioSciences focuses on creating and supplying collagen-based products for wound healing and care. They offer prescription and over-the-counter items like Medifil II and SkinTemp II, along with research and manufacturing services. Based in Gaithersburg, MD, USA, and Ahmedabad, India, they serve patients, professionals, and partners through collaborations and online platforms, emphasizing innovation in healthcare.
Human BioSciences's top competitors include Tempo Therapeutics, Nuo Therapeutics and Claris Bio.
Human BioSciences offers Medifil® II, SkinTemp® II, and Collatek® Gel.
Human BioSciences operates through Human Biosciences India Limited.
The legal entities of Human BioSciences currently have 3 directors, including Kolluru Venkata Surya Prakash, Manoj Kumar Jain, Ashok Kantilal Shah.